haematology
Blood cancers

Liquid biopsy ctDNA testing is now ‘prime time’ for blood cancers

Circulating tumour DNA (ctDNA) testing is starting to make a difference in the management of haematological malignancies in Australia, according to local clinicians. While still largely in the research setting, access to ctDNA genomic testing is being made available to some patients through the Christine and Bruce Wilson Centre for Lymphoma Genomics at the Peter ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic